GUIDELINES ON VALIDATION APPENDIX 6 VALIDATION ON QUALIFICATION OF SYSTEMS, UTILITIES AND EQUIPMENT

Size: px
Start display at page:

Download "GUIDELINES ON VALIDATION APPENDIX 6 VALIDATION ON QUALIFICATION OF SYSTEMS, UTILITIES AND EQUIPMENT"

Transcription

1 June 2016 Draft document for comment GUIDELINES ON VALIDATION APPENDIX 6 VALIDATION ON QUALIFICATION OF SYSTEMS, UTILITIES AND EQUIPMENT World Health Organization 2016 All rights reserved. (June 2016) DRAFT FOR COMMENTS This draft is intended for a restricted audience only, i.e. the individuals and organizations having received this draft. The draft may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means outside these individuals and organizations (including the organizations' concerned staff and member organizations) without the permission of the World Health Organization. The draft should not be displayed on any website. Please send any request for permission to: Should you have any comments on the attached text, please send these to Dr S. Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms (kopps@who.int) with a copy to Ms Marie Gaspard (gaspardm@who.int) by 15 August Medicines Quality Assurance working documents will be sent out electronically only and will also be placed on the Medicines website for comment under Current projects. If you do not already receive our draft working documents please let us have your address (to bonnyw@who.int) and we will add it to our electronic mailing list. Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms, Regulation of Medicines and other Health Technologies, Department of Essential Medicines and Health Products, World Health Organization, CH-1211 Geneva 27, Switzerland. Fax: (41-22) ; kopps@who.int. The designations employed and the presentation of the material in this draft do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this draft. However, the printed material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. This draft does not necessarily represent the decisions or the stated policy of the World Health Organization.

2 page SCHEDULE FOR THE PROPOSED ADOPTION PROCESS OF DOCUMENT QAS/16.673: GUIDELINES ON VALIDATION APPENDIX 6 VALIDATION ON QUALIFICATION OF SYSTEMS, UTILITIES AND EQUIPMENT Discussion of proposed need for revision in view of the current trends in validation during informal consultation on data management, bioequivalence, GMP and medicines inspection Preparation of draft proposal for revision of the main text and several appendices by specialists in collaboration with the Medicines Quality Assurance Group and Prequalification Team (PQT)-Inspections, based on the feedback received during the meeting and from PQT- Inspections, draft proposals developed on the various topics by specialists, as identified in the individual working documents. Presentation of the progress made to the fiftieth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations Discussion at the informal consultation on good practices for health products manufacture and inspection, Geneva Preparation of revised text by Dr A.J. van Zyl, participant at the above-mentioned consultation, based on the feedback received during and after the informal consultation by the meeting participants and members of PQT-Inspections Circulation of revised working document for public consultation Consolidation of comments received and review of feedback Presentation to the fifty-first meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations Any other follow-up action as required 29 June 1 July 2015 July 2015 April October April 2016 May 2016 June 2016 August September October 2016

3 page Background information The need for revision of the published Supplementary guidelines on good manufacturing practices: validation (World Health Organization (WHO) Technical Report Series, No. 937, 2006, Annex 4) was identified by the Prequalification of Medicines Programme and a draft document was circulated for comment in early The focus of the revision was the Appendix on non-sterile process validation (Appendix 7), which had been revised and was adopted by the Committee at its forty-ninth meeting in October The main text was sent out for consultation as Working document QAS/ entitled Guidelines on Validation which constitute the general principles of the new guidance on validation. The draft on the specific topics, the appendices to this main text, will follow. One of them, i.e. the Validation on qualification of systems, utilities and equipment, constitutes this working document. The following is an overview on the appendices that are intended to complement the general text on validation: Appendix 1 Validation of heating, ventilation and air-conditioning systems will be replaced by cross-reference to WHO Guidelines on GMP for HVAC systems for considerations in qualification of HVAC systems (update - working document QAS/15.639/Rev.1) Appendix 2 Validation of water systems for pharmaceutical use will be replaced by cross-reference to WHO Guidelines on water for pharmaceutical use for consideration in qualification of water purification systems Appendix 3 Cleaning validation consensus to retain Appendix 4 Analytical method validation will be replaced by update - working document QAS/ Appendix 5 Validation of computerized systems will be replaced by update - working document QAS/ Appendix 6 Qualification of systems, utilities and equipment updated text proposed in this working document

4 page Appendix 7 Non-sterile process validation update already published as Annex 3, WHO Technical Report Series, No. 992, 2015

5 page GUIDELINES ON VALIDATION APPENDIX 6 VALIDATION ON QUALIFICATION OF SYSTEMS, UTILITIES AND EQUIPMENT 1. Principle 2. Scope 3. Glossary 4. General 5. User requirement specifications 6. Factory acceptance test and site acceptance test 7. Design qualification 8. Installation qualification 9. Operational qualification 10. Performance qualification 11. Requalification 12. Qualification of in use systems and equipment 1. PRINCIPLE 1.1 Systems, utilities and equipment should be appropriately designed, located, installed, operated, cleaned and maintained to suit their intended purpose. 1.2 Products should be manufactured on qualified equipment to ensure batch-to-batch consistency 1.3 Procedures should be in place to ensure that systems, utilities and equipment remain in a qualified state throughout the life of the system, utility and equipment. 2. SCOPE 2.1 These guidelines describe the general aspects of qualification for systems, utilities and equipment. 2.2 The principles in this guideline may also be applied to the qualification of instruments and testing devices, where appropriate. 2.3 Systems, utilities and equipment that may have an impact on the quality of products, should be appropriately qualified. These may include, where appropriate: computerized systems; water purification systems; heating, ventilation and air conditioning systems; compressed air systems; steam systems; production and quality control of equipment and instruments. 2.4 Documented impact assessments should support decisions for the exclusion of systems, utilities and equipment from qualification.

6 page GLOSSARY design qualification. Documented evidence that the premises, supporting systems, utilities, equipment and processes have been designed in accordance with the requirements of good manufacturing practices. factory acceptance test. A test conducted at the vendor s premises to verify that the system, equipment or utility, as assembled or partially assembled, meets expected specifications. (new) installation qualification. The performance of tests to ensure that the installations (such as machines, measuring devices, utilities and manufacturing areas) used in a manufacturing process are appropriately selected and correctly installed and operate in accordance with established specifications. operational qualification. Documented verification that the system or subsystem performs as intended over all anticipated operating ranges. performance qualification. Documented verification that the equipment or system operates consistently and gives reproducibility within defined specifications and parameters for prolonged periods. (In the context of systems, the term process validation may also be used.) site acceptance test. A test conducted at the site of use to verify that the system, equipment or utility, as assembled or partially assembled meets expected specifications. (new) system. A regulated pattern of interacting activities and techniques that are united to form an organized whole. user requirement specifications. An authorized document that defines the requirements for use of the system, equipment or utility in its intended production environment. (amended) utility. A system consisting of one or more components to form a structure designed to collectively operate, function or perform and provide a service such as electricity, water, ventilation or other. (new) 4. GENERAL 4.1 The validation master plan, or other relevant document, should specify the policy, organization, planning, scope and stages applied in qualification for systems, utilities and equipment and should cover, e.g. production, quality control and engineering. 4.2 The scope and extent of qualification and requalification should be determined based on the principles of impact assessment and risk assessment. Risk management principles should be considered in all areas of the scope and stages of qualification.

7 Design Qualification page Where appropriate, new systems, utilities and equipment should pass through all stages of qualification including the preparation of user requirement specifications (URS), design qualification (DQ), installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ) (see Figure 1 as an example). Figure 1. Examples of stages of qualification V-Model for Direct Impact Systems User Requirement Specification PQ Test Plan (incl. UAT) Performance Qualification Functional Design Specification OQ Test Plan (incl. FAT) Operational Qualification DQ Test Plan Detail Design and Configuration Specifications IQ Test Plan (incl. PDI) Installation Qualification Build & Project Implementation (Note: For description of stages, see below) 4.4 Scientific justification should be provided where it is decided that not all stages of qualification are required. [Note from the Secretariat: The references below will be updated upon finalization of the related texts.] 4.5 See WHO TRS XXX for aspects to be considered for inclusion in qualification of water purification systems 4.6 See WHO TRS XXX for aspects to be considered for inclusion in qualification of heating, ventilation and air-conditioning (HVAC) systems. 4.7 See WHO TRS XXX for aspects to be considered for inclusion in qualification and validation of computerized systems.

8 page Qualification should be done in accordance with predetermined and approved qualification protocols. 4.9 The results of the qualification should be recorded and reflected in qualification reports Rooms or areas, as appropriate, should be qualified prior to the qualification of utilities Utilities should be qualified prior to the qualification of equipment Equipment should qualified and brought into routine use only once there is documented evidence that it is fit for its intended purpose Certain stages of the qualification may be done by the supplier or a third party, subject to the conditions and responsibilities as defined in an agreement between the two parties. The contract giver remains responsible to ensure that the qualification is done in accordance with good manufacturing practices (GMP) There should be a logical sequence in performing qualification. For example, operational qualification should follow after the successful completion of installation qualification The relevant documentation associated with qualification including standard operating procedures (SOPs), specifications and acceptance criteria, certificates and manuals should be maintained and be traceable Systems, utilities and equipment should be maintained in a qualified state and undergo periodic requalification where appropriate, as well as requalification after change when needed Processes should be validated on qualified equipment. 5. USER REQUIREMENT SPECIFICATIONS 5.1 URS should be prepared for systems, utilities and equipment, where appropriate 5.2 URS should be used to verify, at a later stage, that the purchased and supplied system, utility or equipment is in accordance with the manufacturer s needs as specified. 6. FACTORY ACCEPTANCE TEST AND SITE ACCEPTANCE TEST 6.1 Where a system, utility or equipment is assembled, or partially assembled at a site other than that of the purchaser or end-user, testing and verification should be done to ensure that the system, utility or equipment is appropriate and ready for dispatch. 6.2 The checks and tests during assembly or partial assemble, should be recorded.

9 page The acceptability of the assembly and overall status of the system, utility or equipment should be described in a conclusion of the report for the factory acceptance test (FAT), prior to shipment. 6.4 When the system, utility or equipment is received at the end user, tests should be performed to verify the acceptability of the system, utility or equipment. 6.5 The results of the tests should be recorded and the outcome of the acceptability of the system, utility or equipment recorded in the conclusion of the report for the site acceptance test (SAT). 7. DESIGN QUALIFICATION 7.1 URS should be considered when deciding on the specific design of a system, utility or equipment. 7.2 A suitable supplier should be selected for the appropriate system, utility or equipment. 7.3 The supplier should be approved prior to purchasing the system, utility or equipment 7.4 On delivery of the system, utility or equipment, the user should verify that it meets the agreed design specifications and satisfies the URS 7.5 Once DQ is completed, IQ may commence. 8. INSTALLATION QUALIFICATION 8.1 Systems, utilities and equipment should be correctly installed, in an appropriate location and in accordance with an installation plan 8.2 There should be documented evidence of the installation. This should be in accordance with the IQ protocol which contains all the required detail. 8.3 IQ should include identification and verification of all system elements, parts, services, controls, gauges and other components. 8.4 Measuring, control and indicating devices being installed should be calibrated. The calibration should be traceable to relevant national or international standards. Certificates should be available. 8.5 The execution of the protocol should be recorded in the IQ report. 8.6 The report should include at least the title, objective, site, details of the supplier and manufacturer, system or equipment name and unique identification number, model and serial number, date of installation, components and their identification numbers or codes, actual results

10 page of tests and measurements, spare parts list, relevant procedures followed for tests and certificates as applicable. 8.7 All deviations and non-conformances from URS, DQ and acceptance criteria specified, observed during installation, should be recorded and investigated. 8.8 The outcome of the IQ should be recorded in the conclusion of the report, before OQ is started. 8.9 Requirements and procedures for calibration, maintenance and cleaning should be drawn up during installation. Figure 2. Example of an installation qualification protocol

11 359 page 11

12 360 page 12

13 361 page 13

14 362 page 14

15 page OPERATIONAL QUALIFICATION 9.1 Systems, utilities and equipment should operate correctly and their operation should be verified in accordance with an OQ protocol. 9.2 Critical operating parameters should be identified. Studies on the critical variables should include conditions encompassing normal, upper and lower operating limits and circumstances (this includes worst-case conditions ).

16 page OQ should include verification of operation of all system elements, parts, services, controls, gauges and other components. 9.4 The results for the verification of operation should be documented in the OQ report to indicate the satisfactory operation. 9.5 SOPs for the operation should be finalized and approved during this phase of qualification. 9.6 Training of operators for the systems, utilities and equipment should be provided and training records maintained. 9.7 Systems, utilities and equipment, as appropriate, should be released for PQ or routine use after completion of OQ. 9.8 All calibration, cleaning, maintenance, training and related tests and results should be verified to be acceptable. Any discrepancy or deviation should be recorded and investigated. 9.9 The outcome of the OQ should be recorded in the conclusion of the report, before PQ is started. Figure 3. Example of an operational qualification protocol

17 page 17

18 399 page 18

19 400 page 19

20 401 page 20

21 402 page 21

22 403 page 22

23 404 page 23

24 405 page 24

25 406 page 25

26 407 page 26

27 page PERFORMANCE QUALIFICATION 10.1 Systems, utilities and equipment should consistently perform in accordance with their design specifications. The performance should be verified in accordance with a PQ protocol There should be records for the PQ (report) to indicate the satisfactory performance over a period of time. Manufacturers should justify the selected period over which PQ is done PQ should be done once OQ is successfully completed Where two stages of qualification (e.g. OQ and PQ) are performed simultaneously, or where PQ is executed at the same time as process validation, appropriate justification for such a decision should be documented Figure 4. Example of a performance qualification protocol

28 page 28

29 430 page 29

30 431 page 30

31 432 page 31

32 433 page 32

33 434 page 33

34 435 page 34

35 436 page 35

36 page REQUALIFICATION 11.1 Systems, utilities and equipment should be maintained in a qualified state through the life of the system, utility or equipment Routine requalification of systems, utilities and equipment should be considered based on the outcome of risk management principles which include factors such as calibration, verification and maintenance data and information The qualification status and requalification due dates should be documented in a defined schedule The scope and extent of qualification should be determined based on risk assessment when changes to an existing system, utility or equipment are made. 12. QUALIFICATION OF IN-USE SYSTEMS, UTILITIES AND EQUIPMENT 12.1 There should be data to support and verify the suitable design, operation and performance of systems, utilities and equipment that have been in use for a period of time and which have not been subjected to IQ and or OQ In such cases, a qualification protocol and report should be prepared where elements of design, operation and performance are verified for acceptability. These should include operating parameters and limits for critical variables, calibration, maintenance and preventive maintenance, SOPs and records. ***

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:

More information

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal

More information

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES February 2013 RESTRICTED GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES DRAFT FOR COMMENT Should you have any comments on the attached text, please send these to Dr Sabine Kopp, Manager, Medicines

More information

GUIDELINES ON VALIDATION APPENDIX 5 VALIDATION OF COMPUTERIZED SYSTEMS

GUIDELINES ON VALIDATION APPENDIX 5 VALIDATION OF COMPUTERIZED SYSTEMS May 2016 Draft document for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 GUIDELINES ON VALIDATION APPENDIX

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/INF 11/2015 1 April 2015 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * * Entry into force:

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control

More information

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Working document QAS/03.055/Rev.2 RESTRICTED SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION This document has followed

More information

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PARACETAMOL ORAL SUSPENSION (September 2010)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PARACETAMOL ORAL SUSPENSION (September 2010) September 2010 RESTRICTED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PARACETAMOL ORAL SUSPENSION (September 2010) DRAFT FOR COMMENTS This document was provided by a quality control expert and

More information

ZINC ACETATE Draft proposal for The International Pharmacopoeia (August 2012)

ZINC ACETATE Draft proposal for The International Pharmacopoeia (August 2012) August 2012 RESTRICTED ZINC ACETATE Draft proposal for The International Pharmacopoeia (August 2012) Draft for discussion This document was provided by a quality control expert. Should you have any comments

More information

Guidance on Qualification of existing facilities, systems, equipment and utilities

Guidance on Qualification of existing facilities, systems, equipment and utilities QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 1 / 16 1. Acknowledgement...3 2. Introduction...3 3. Scope...4 4. Regulatory requirements...4 5. Guidance...4 5.1 Risk Assessment... 4 5.2 Procedure... 7 5.3

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

OPERATIONAL STANDARD

OPERATIONAL STANDARD 1 of 11 1. Introduction The International Safe Transit Association (ISTA), a non-profit association whose objective is to prevent product damage and excess packaging usage within the distribution environment.

More information

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1 Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and

More information

LUMEFANTRINE Draft proposal for The International Pharmacopoeia (October 2006)

LUMEFANTRINE Draft proposal for The International Pharmacopoeia (October 2006) October 2006 RESTRICTED LUMEFANTRINE Draft proposal for The International Pharmacopoeia (October 2006) DRAFT FOR DISCUSSION World Health Organization 2006 All rights reserved. This draft is intended for

More information

Annex 4 Supplementary guidelines on good manufacturing practices: validation

Annex 4 Supplementary guidelines on good manufacturing practices: validation World Health Organization WHO Technical Report Series, No. 937, 2006 Annex 4 Supplementary guidelines on good manufacturing practices: validation 1. Introduction 2. Scope 3. Glossary 4. Relationship between

More information

Computer-Aided Facilities Management - A Logical Trend

Computer-Aided Facilities Management - A Logical Trend Computer-Aided Facilities Management - A Logical Trend Two major organisational changes are part of the modern pharmaceutical industry scene. Firstly, mergers as companies seek to consolidate resources

More information

Testing Automated Manufacturing Processes

Testing Automated Manufacturing Processes Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls

More information

WHO GUIDELINE ON QUALITY RISK MANAGEMENT

WHO GUIDELINE ON QUALITY RISK MANAGEMENT August 2012 RESTRICTED WHO GUIDELINE ON QUALITY RISK MANAGEMENT REVISED DRAFT FOR COMMENT Please address any comments on this proposal, by 5 October 2012 to Dr S. Kopp, Medicines Quality Assurance Programme,

More information

International Health Regulations

International Health Regulations International Health Regulations World Health Organization 2008 WHO/CDS/EPR/IHR/2007.2 WHO Lyon Office for National Epidemic Preparedness and Response 58, avenue Debourg, 69007 Lyon, France Tel: +33 (0)4

More information

Annex 7 Guidelines on pre-approval inspections

Annex 7 Guidelines on pre-approval inspections World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the

More information

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

FAT Factory Acceptance Testing SAT Site Acceptance Testing

FAT Factory Acceptance Testing SAT Site Acceptance Testing FAT Factory Acceptance Testing SAT Site Acceptance Testing Dr. Ingrid Walther May 2015, Page 1 Factory Acceptance Testing - FAT Site Acceptance Testing - SAT FAT and SAT - Important Milestones in the Project

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex

More information

GAMP5 - a lifecycle management framework for customized bioprocess solutions

GAMP5 - a lifecycle management framework for customized bioprocess solutions GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),

More information

Validation and Calibration. Definitions and Terminology

Validation and Calibration. Definitions and Terminology Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an

More information

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known

More information

In 2001, ISPE issued Baseline Guide Volume

In 2001, ISPE issued Baseline Guide Volume In today s biopharma and pharmaceutical industries, three related, but distinct terms are in common use: commissioning, qualification, and verification. Inconsistent interpretation and application of these

More information

Installation and Operational Qualification Protocol (Reference: SOP )

Installation and Operational Qualification Protocol (Reference: SOP ) Project Name Equipment Process Line/Location Project Number Serial Number Model Number Protocol number WRITTEN BY: REVIEWED BY: Position APPROVAL TO EXECUTE: Position: PROTOCOL COMPLETION APPROVAL: Position:

More information

Guidelines for Validation & Qualification, including Change Control, for Hospital Transfusion Laboratories

Guidelines for Validation & Qualification, including Change Control, for Hospital Transfusion Laboratories Guidelines for Validation & Qualification, including Change Control, for Hospital Transfusion Laboratories British Committee for Standards in Haematology Address for correspondence: BCSH Secretary British

More information

Computerised Systems. Seeing the Wood from the Trees

Computerised Systems. Seeing the Wood from the Trees Computerised Systems Seeing the Wood from the Trees Scope WHAT IS A COMPUTERISED SYSTEM? WHY DO WE NEED VALIDATED SYSTEMS? WHAT NEEDS VALIDATING? HOW DO WE PERFORM CSV? WHO DOES WHAT? IT S VALIDATED -

More information

Guide for Documenting and Sharing Best Practices. in Health Programmes

Guide for Documenting and Sharing Best Practices. in Health Programmes Guide for Documenting and Sharing Best Practices in Health Programmes Guide for Documenting and Sharing Best Practices in Health Programmes WORLD HEALTH ORGANIZATION Regional Office for Africa Brazzaville

More information

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction

More information

White paper: FDA Guidance for Industry Update Process Validation

White paper: FDA Guidance for Industry Update Process Validation White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,

More information

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division

More information

1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.

More information

Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles

Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles Introduction 37 General considerations 39 Glossary

More information

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Geneva, 18 to 22 October 2010

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Geneva, 18 to 22 October 2010 ENGLISH ONLY EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Geneva, 18 to 22 October 2010 Proposal to initiate a project to evaluate a

More information

WHO GUIDELINE ON QUALITY RISK MANAGEMENT

WHO GUIDELINE ON QUALITY RISK MANAGEMENT August 2010 RESTRICTED WHO GUIDELINE ON QUALITY RISK MANAGEMENT This guideline has been prepared by Dr Simon Mills, United Kingdom. Please address any comments on this proposal, by 1 October 2010 to Dr

More information

Adoption by GCP Inspectors Working Group for consultation 14 June 2011. End of consultation (deadline for comments) 15 February 2012

Adoption by GCP Inspectors Working Group for consultation 14 June 2011. End of consultation (deadline for comments) 15 February 2012 10 December 2013 EMA/INS/GCP/600788/2011 Compliance and Inspection Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials, with particular

More information

EQUIPMENT QUALIFICATION AND VALIDATION OF TABLET COMPRESSION MACHINE

EQUIPMENT QUALIFICATION AND VALIDATION OF TABLET COMPRESSION MACHINE WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES P.Ramasubramaniyan et al. Volume 2, Issue 6, 5412-5418. Research Article ISSN 2278 4357 EQUIPMENT QUALIFICATION AND VALIDATION OF TABLET COMPRESSION

More information

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) Presented by: Patrick Costello Scientific Administrator, European Medicines Agency An agency of the European

More information

World Health Organization Prequalification of Medicines

World Health Organization Prequalification of Medicines Dr André van Zyl World Health Organization Prequalification of Medicines Manufacturers meeting April 2011 Head of Inspections vanzyla@who.int 1 WHO GMP In this presentation: Background and Introduction

More information

Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements

Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements Dr. Dirk Feldmann Prof. Dr. Hans-Jörg Müller Aim of the study I.) Comparison of the EU and WHO GMP

More information

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) Nutrition Supplier Meeting, June 30, 2015 Dimitris Catsoulacos Quality Assurance Specialist PRESENTATION OVERVIEW Quality

More information

AN OVERVIEW OF PHARMACEUTICAL VALIDATION: QUALITY ASSURANCE VIEW POINT

AN OVERVIEW OF PHARMACEUTICAL VALIDATION: QUALITY ASSURANCE VIEW POINT INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Review Article AN OVERVIEW OF PHARMACEUTICAL VALIDATION: QUALITY ASSURANCE VIEW POINT L. Nandhakumar*, G. Dharmamoorthy,

More information

Qualification of temperature-controlled storage areas

Qualification of temperature-controlled storage areas WHO Vaccine Qualification of temperature-controlled storage areas Technical supplement to WHO Technical Report Series, No. 961, 2011 Annex 9: Model guidance for the storage and transport of time and temperature

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

This interpretation of the revised Annex

This interpretation of the revised Annex Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation

More information

Quality assurance of pharmaceuticals

Quality assurance of pharmaceuticals QAPPR 12/16/06 12:10 PM Page i Quality assurance of pharmaceuticals A compendium of guidelines and related materials Volume 2, 2nd updated edition Good manufacturing practices and inspection QAPPR 12/16/06

More information

What is Process Validation?

What is Process Validation? What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process

More information

FDA Guidance for Industry Update - Process Validation

FDA Guidance for Industry Update - Process Validation FDA Guidance Update: Process Validation: General Principles and Practices White Paper FDA Guidance for Industry Update - Process Validation The changing face of Validation; are IQ, OQ and PQ really dead

More information

OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD

OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD 1. The following draft Advisory Document will replace the 1995 OECD GLP Consensus Document number 10

More information

WHO GUIDELINE ON TRANSFER OF TECHNOLOGY

WHO GUIDELINE ON TRANSFER OF TECHNOLOGY September 2009 RESTRICTED WHO GUIDELINE ON TRANSFER OF TECHNOLOGY DRAFT DOCUMENT FOR COMMENT The need for new WHO guidance for transfer of technology was discussed at the fortysecond meeting of the WHO

More information

Spillemyndigheden s change management programme. Version 1.3.0 of 1 July 2012

Spillemyndigheden s change management programme. Version 1.3.0 of 1 July 2012 Version 1.3.0 of 1 July 2012 Contents 1 Introduction... 3 1.1 Authority... 3 1.2 Objective... 3 1.3 Target audience... 3 1.4 Version... 3 1.5 Enquiries... 3 2. Framework for managing system changes...

More information

Process Validation: Practical Aspects of the New FDA Guidance

Process Validation: Practical Aspects of the New FDA Guidance Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products- authorisations, European Medicines Agency Brussels, EudraLex The Rules Governing Medicinal

More information

Installation, Operation and Performance Qualification of a Thermoguard Installation

Installation, Operation and Performance Qualification of a Thermoguard Installation Installation, Operation and Performance Qualification of a Thermoguard Installation Thermoguard Qualification in Accordance with GMP To operate Thermoguard hardware and software within a regulated environment

More information

ICH guideline Q10 on pharmaceutical quality system

ICH guideline Q10 on pharmaceutical quality system September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final

More information

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality

More information

Process Validation for Medical Devices

Process Validation for Medical Devices Process Validation for Medical Devices Dan O Leary CBA, CQE, CRE, CSSBB, CIRM, LLC 603-209-0600 OmbuEnterprises@msn.com Copyright 2010 by, LLC Process Validation for Medical Devices 1 Instructor Introduction

More information

UNICEF s Quality Assurance System for procurement of medicines

UNICEF s Quality Assurance System for procurement of medicines UNICEF s Quality Assurance System for procurement of medicines QA Specialist Peter Svarrer Jakobsen Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers UN City, Copenhagen 23 September

More information

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 December 2010 EMA/CHMP/ICH/265145/ Committee for medicinal products for human use (CHMP) ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 Step 5 Transmission to CHMP for information December

More information

ISO 9001:2008 Quality Management System Requirements (Third Revision)

ISO 9001:2008 Quality Management System Requirements (Third Revision) ISO 9001:2008 Quality Management System Requirements (Third Revision) Contents Page 1 Scope 1 1.1 General. 1 1.2 Application.. 1 2 Normative references.. 1 3 Terms and definitions. 1 4 Quality management

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

UNCONTROLLED COPY FOR REFERENCE ONLY

UNCONTROLLED COPY FOR REFERENCE ONLY CLOVER MACHINE AND MFG. 800 MATHEW ST. #101 SANTA CLARA, CA 95050 727-3380 727-7015 fax REVISION: DATE: PAGE 1 OF 45 QUALITY POLICY MANUAL DISTRIBUTION LIST: President Purchasing Manager Vice President

More information

(WHO Technical Report Series, No. 961, 2011), Annex 9. Temperature and humidity monitoring systems for fixed storage areas 107

(WHO Technical Report Series, No. 961, 2011), Annex 9. Temperature and humidity monitoring systems for fixed storage areas 107 Annex 5 Technical supplements to Model guidance for the storage and transport of timeand temperature-sensitive pharmaceutical products (WHO Technical Report Series, No. 961, 2011), Annex 9 1. The technical

More information

How to implement a Quality Management System

How to implement a Quality Management System How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your

More information

Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003. Change Control

Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003. Change Control Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003 Change Control Wolfgang Schumacher Roche Pharmaceuticals, Basel Agenda Change Control Definitions

More information

PHYTOSANITARY CERTIFICATION SYSTEM

PHYTOSANITARY CERTIFICATION SYSTEM ISPM 7 INTERNATIONAL STANDARDS FOR PHYTOSANITARY MEASURES ISPM 7 PHYTOSANITARY CERTIFICATION SYSTEM (2011) Produced by the Secretariat of the International Plant Protection Convention FAO 2011 ISPM 7 Phytosanitary

More information

Temperature mapping of storage areas Technical supplement to WHO Technical Report Series, No. 961, 2011

Temperature mapping of storage areas Technical supplement to WHO Technical Report Series, No. 961, 2011 WHO Vaccine Temperature mapping of storage areas Technical supplement to WHO Technical Report Series, No. 961, 2011 Annex 9: Model guidance for the storage and transport of time and temperature sensitive

More information

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT Guideline Title Specifications and Control Tests on the Finished Product Legislative basis Directive 75/318/EEC as amended Date of first adoption

More information

VALIDATION OF CLEAN ROOMS FOR ASEPTIC MANUFACTURING. F.R.Smal Pharmaceutical Director ICCE ICCE a member of SNC-Lavalin Group

VALIDATION OF CLEAN ROOMS FOR ASEPTIC MANUFACTURING. F.R.Smal Pharmaceutical Director ICCE ICCE a member of SNC-Lavalin Group VALIDATION OF CLEAN ROOMS FOR ASEPTIC MANUFACTURING F.R.Smal Pharmaceutical Director ICCE ICCE a member of SNC-Lavalin Group tel + 3226431600 E-Mail: francis.smal@be.snclavalin.com VALIDATION OF CLEAN

More information

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR WHO/FWC/IVB/QSS/VQR 2011 This guidance document GUIDE TO MASTER FORMULAE is one of a series developed by WHO/FWC/IVB Quality, Safety & Standards team upon request from the manufacturers members of the

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials

Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials 1 2 3 5 August 2011 EMA/INS/GCP/600788/2011 Compliance and Inspection 4 5 6 7 Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials

More information

ITS specification Handover and commissioning process (ITS-10-01)

ITS specification Handover and commissioning process (ITS-10-01) ITS specification Handover and commissioning process (ITS-10-01) NZ Transport Agency Effective from September 2011 Copyright information This publication is copyright NZ Transport Agency (NZTA). Material

More information

Contamination Control and Environmental Monitoring Systems

Contamination Control and Environmental Monitoring Systems Life Science Contamination Control and Environmental Monitoring Systems Hospital Electronics Brookhaven Instruments deliver, install and validate particle counters, Microbial Air Samplers and Monitoring

More information

GOOD DISTRIBUTION PRACTICES (GDP) FOR PHARMACEUTICAL PRODUCTS

GOOD DISTRIBUTION PRACTICES (GDP) FOR PHARMACEUTICAL PRODUCTS WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Working document QAS/04.068/Rev.2 RESTRICTED GOOD DISTRIBUTION PRACTICES (GDP) FOR PHARMACEUTICAL PRODUCTS This document has followed the steps

More information

Building Commissioning 17900-1

Building Commissioning 17900-1 SECTION 17900 BUILDING COMMISSIONING PART 1 - GENERAL 1.01 WORK DESCRIPTION: A. General: 1. The Commissioning process is a joint team effort to ensure that all mechanical equipment, controls, and systems

More information

GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS

GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 011-3 25 September 2007 PIC/S GUIDANCE GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS PIC/S

More information

Packaging Validation Protocol (Reference: SOP )

Packaging Validation Protocol (Reference: SOP ) Project Name Equipment Manufacturer Process Line/Location Project Number Serial Number Model Number Protocol number WRITTEN BY: REVIEWED BY: Position APPROVAL TO EXECUTE: PROTOCOL COMPLETION APPROVAL:

More information

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 9.1 Status : APPROVED Effective: 12/11/2014 Page 2 of 23 Quality Manual Table of Contents

More information

Considerations When Validating Your Analyst Software Per GAMP 5

Considerations When Validating Your Analyst Software Per GAMP 5 WHITE PAPER Analyst Software Validation Service Considerations When Validating Your Analyst Software Per GAMP 5 Blair C. James, Stacy D. Nelson Introduction The purpose of this white paper is to assist

More information

Sharon Strause 9/10/2010. 15 years with the

Sharon Strause 9/10/2010. 15 years with the Manage Software Development, Testing, and Validation Presented by Sharon Strause, Senior Consultant EduQuest, Inc. IVT s Computer and Software Validation EU Conference The Hilton Dublin Dublin, Ireland

More information

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. Supplier Quality Standard 1.0 Purpose The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. These expectations

More information

Selection and use of ISO 9000

Selection and use of ISO 9000 Selection and use of ISO 9000 ISO in brief ISO is the International Organization for Standardization. It is made up of national standards institutes from countries large and small, industrialized and developing,

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064587 EudraLex The Rules Governing Medicinal Products

More information

Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development

Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development Unclassified ENV/JM/MONO(2016)13 ENV/JM/MONO(2016)13 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 22-Apr-2016 English

More information

GAMP 5 and the Supplier Leveraging supplier advantage out of compliance

GAMP 5 and the Supplier Leveraging supplier advantage out of compliance GAMP 5 and the Supplier Leveraging supplier advantage out of compliance Paul Osborne Performance PharmaTech Ltd. Overview This document is designed to assist suppliers who wish to sell computer based equipment

More information

Best practices for computerised systems in regulated GxP environments.

Best practices for computerised systems in regulated GxP environments. PIC/S Logo PHARMACEUTICAL INSPECTION PH/W 01/2000 (DRAFT) CONVENTION January 2000 PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PIC/S Guidance Best practices for computerised systems in regulated GxP environments.

More information

WHO Expert Committee on Specifications for Pharmaceutical Preparations. How does it work?

WHO Expert Committee on Specifications for Pharmaceutical Preparations. How does it work? 1 WHO Expert Committee on Specifications for Pharmaceutical Preparations How does it work? Sabine Kopp, PhD Quality Assurance and Safety: Medicines Department of Medicines Policy and Standards Main points

More information

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 9.2 Status : APPROVED Effective: 9/25/2015 Page 2 of 23 Quality Manual Table of Contents

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Quality Management System Manual

Quality Management System Manual Quality Management System Manual Assurance ISO / AS Manual Quality Management System EXCEEDING ALL EXPECTATIONS Since our inception in 1965, Swiss-Tech has supplied the medical, aerospace, hydraulic, electronic

More information